Company News
ARI Pune Develops Targeted Breast Cancer Nanomedicine
Agharkar Research Institute scientists developed a biodegradable nanocarrier for targeted gene therapy in breast cancer.
The MUC1-targeted system delivers siRNA to silence two anti-apoptotic genes (MC
